Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
k6c5TTNSbhh5Mudt
Listen
